Cargando…
Antibody–Drug Conjugate that Exhibits Synergistic Cytotoxicity with an Endosome–Disruptive Peptide
[Image: see text] Antibody–drug conjugates are an important class of cancer therapeutics. These agents generally bind a specific cell surface receptor, undergo receptor-mediated endocytosis, and enter the endosomal–lysosomal system, where the environment in these organelles facilitates the release o...
Autores principales: | Knewtson, Kelsey E., Perera, Chamani, Hymel, David, Gao, Zhe, Lee, Molly M., Peterson, Blake R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6690568/ https://www.ncbi.nlm.nih.gov/pubmed/31460422 http://dx.doi.org/10.1021/acsomega.9b01585 |
Ejemplares similares
-
Conjugates of Ciprofloxacin and Levofloxacin with Cell-Penetrating Peptide Exhibit Antifungal Activity and Mammalian Cytotoxicity
por: Ptaszyńska, Natalia, et al.
Publicado: (2020) -
Synergistic Antitumor Activity from Two-Stage Delivery
of Targeted Toxins and Endosome-Disrupting Nanoparticles
por: Su, Xingfang, et al.
Publicado: (2013) -
Synthetic Ionizable Colloidal Drug Aggregates Enable Endosomal Disruption
por: Donders, Eric N., et al.
Publicado: (2023) -
Short peptides conjugated to non-peptidic motifs exhibit antibacterial activity
por: Ardila-Chantré, Natalia, et al.
Publicado: (2020) -
Synergistic effects of Ferula gummosa and radiotherapy on induction of cytotoxicity in HeLa cell line
por: Forouzmand, Seyed Hamid, et al.
Publicado: (2018)